Nanodropper, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients (NCT05181046) | Nanodropper, Inc. | 2021-11-06 |
Track Nanodropper, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.